The Sun Pharma stock on Monday rose the most on BSE after the firm reported a 7% rise in net for the quarter ended March 31, 2018 . At 9:44 am, the stock was trading 5.83% or 27 points higher at 493.75 on BSE. The stock rose up to 6.84% to hit a high of 498.50 on BSE.
The company's sales in the US stood at $368 million for the fourth quarter quarter, a de-growth of 3 per cent over same period last year. For 2017-18, sales stood at $1,357 million , a decline of 34 per cent over 2016-17.